Galderisi, Alfonso

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 152

Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort–Based Study

Sousa, G. R., Pober, D., Galderisi, A., Lv, H., Yu, L., Pereira, A. C., Doria, A., Kosiborod, M., & Lipes, M. A. (2019) · Circulation

Diabetes and associated disordersDiabetes Management and Research

Cited by 117

Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe

Del Favero, S., Boscari, F., Messori, M., Rabbone, I., Bonfanti, R., Sabbion, A., Iafusco, D., Schiaffini, R., Visentin, R., Calore, R., et al. (2016) · Diabetes Care

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 94

Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions

Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 92

Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting

Troncone, A., Bonfanti, R., Iafusco, D., Rabbone, I., Sabbion, A., Schiaffini, R., Galderisi, A., Marigliano, M., Rapini, N., Rigamonti, A., et al. (2016) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 33

Effect of Afrezza on Glucose Dynamics During HCL Treatment

Galderisi, A., Cohen, N., Calhoun, P., Kraemer, K., Breton, M., Weinzimer, S., & Cengiz, E. (2020) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 32

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Galderisi, A., Sherr, J., VanName, M., Carria, L., Zgorski, M., Tichy, E., Weyman, K., Cengiz, E., Weinzimer, S., & Tamborlane, W. (2018) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 25

Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling

Lo Presti, J., Galderisi, A., Doyle, F. J., Zisser, H. C., Dassau, E., Renard, E., Toffanin, C., & Cobelli, C. (2023) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 12

In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing

Dalla Libera, A., Toffanin, C., Drecogna, M., Galderisi, A., Pillonetto, G., & Cobelli, C. (2023) · APL Bioengineering

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 8

A New Index of Insulin Sensitivity from Glucose Sensor and Insulin Pump Data: In Silico and In Vivo Validation in Youths with Type 1 Diabetes

Schiavon, M., Galderisi, A., Basu, A., Kudva, Y. C., Cengiz, E., & Dalla Man, C. (2023) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 8